These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 11164847

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
    Brixius K, Bundkirchen A, Bölck B, Mehlhorn U, Schwinger RH.
    Br J Pharmacol; 2001 Aug; 133(8):1330-8. PubMed ID: 11498519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
    Böhm M, Ettelbrück S, Flesch M, van Gilst WH, Knorr A, Maack C, Pinto YM, Paul M, Teisman AC, Zolk O.
    Cardiovasc Res; 1998 Oct; 40(1):146-55. PubMed ID: 9876327
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
    Kindermann M, Maack C, Schaller S, Finkler N, Schmidt KI, Läer S, Wuttke H, Schäfers HJ, Böhm M.
    Circulation; 2004 Jun 29; 109(25):3182-90. PubMed ID: 15184276
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of catecholamines on function of the rat right heart.
    Irlbeck M, Zimmer HG.
    Cardiovasc Res; 1993 Dec 29; 27(12):2146-51. PubMed ID: 7906201
    [Abstract] [Full Text] [Related]

  • 8. kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta1-adrenoceptor stimulation in the rat.
    Shan D, Wang H, Su Y, Jing Y, Wong TM.
    Eur J Pharmacol; 2007 Jan 26; 555(2-3):100-5. PubMed ID: 17126321
    [Abstract] [Full Text] [Related]

  • 9. Blockade of putative beta4- and beta1-adrenoceptors by carvedilol in ferret myocardium.
    Lowe MD, Grace AA, Kaumann AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 May 26; 359(5):400-3. PubMed ID: 10498290
    [Abstract] [Full Text] [Related]

  • 10. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
    Molenaar P, Christ T, Ravens U, Kaumann A.
    Cardiovasc Res; 2006 Jan 26; 69(1):128-39. PubMed ID: 16225854
    [Abstract] [Full Text] [Related]

  • 11. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.
    Eur J Heart Fail; 2005 Jun 26; 7(4):618-23. PubMed ID: 15921803
    [Abstract] [Full Text] [Related]

  • 12. Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes.
    Kurosaki K, Ikeda U, Maeda Y, Shimada K.
    J Mol Cell Cardiol; 2000 Feb 26; 32(2):333-9. PubMed ID: 10722808
    [Abstract] [Full Text] [Related]

  • 13. Effect of beta-blockers on free radical-induced cardiac contractile dysfunction.
    Flesch M, Maack C, Cremers B, Bäumer AT, Südkamp M, Böhm M.
    Circulation; 1999 Jul 27; 100(4):346-53. PubMed ID: 10421593
    [Abstract] [Full Text] [Related]

  • 14. Characteristic effects of alpha1-beta1,2-adrenergic blocking agent, carvedilol, on [Ca2+]i in ventricular myocytes compared with those of timolol and atenolol.
    Yao A, Kohmoto O, Oyama T, Sugishita Y, Shimizu T, Harada K, Matsui H, Komuro I, Nagai R, Matsuo H, Serizawa T, Maruyama T, Takahashi T.
    Circ J; 2003 Jan 27; 67(1):83-90. PubMed ID: 12520158
    [Abstract] [Full Text] [Related]

  • 15. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
    Zhao Q, Wu TG, Jiang ZF, Chen GW, Lin Y, Wang LX.
    Cardiovasc Drugs Ther; 2007 Apr 27; 21(2):85-90. PubMed ID: 17440824
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage.
    Ozakca I, Arioglu-Inan E, Esfahani H, Altan VM, Balligand JL, Kayki-Mutlu G, Ozcelikay AT.
    Am J Physiol Heart Circ Physiol; 2013 May 27; 304(9):H1267-76. PubMed ID: 23457011
    [Abstract] [Full Text] [Related]

  • 17. Receptor pharmacology of carvedilol in the human heart.
    Bristow MR, Larrabee P, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD, Müller-Beckmann B.
    J Cardiovasc Pharmacol; 1992 May 27; 19 Suppl 1():S68-80. PubMed ID: 1378154
    [Abstract] [Full Text] [Related]

  • 18. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
    Feuerstein G, Liu GL, Yue TL, Cheng HY, Hieble JP, Arch JR, Ruffolo RR, Ma XL.
    Eur J Pharmacol; 1998 Jun 26; 351(3):341-50. PubMed ID: 9721026
    [Abstract] [Full Text] [Related]

  • 19. Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure overload: effects of beta-receptor blockade.
    Grimm D, Huber M, Jabusch HC, Shakibaei M, Fredersdorf S, Paul M, Riegger GA, Kromer EP.
    J Mol Cell Cardiol; 2001 Mar 26; 33(3):487-501. PubMed ID: 11181017
    [Abstract] [Full Text] [Related]

  • 20. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H, Sakabe A, Maehara K, Maruyama Y.
    Circulation; 2002 Feb 26; 105(8):975-80. PubMed ID: 11864928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.